A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma

Clinical trial NCT01781572 · COMPLETED

Trial details

NCT number: NCT01781572
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic NRAS Mutant Melanoma

Start date: 2013-06-01
Primary completion: 2018-01-15
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.